| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AUPHAurinia Pharmaceuticals Inc. | 1.96B | 14.87 | 378.37 | 33.97% | 29.28% | 21.28% | 2.25% | 0.21 |
| ARGXargenx SE | 50.33B | 813.24 | 63.63 | 78.6% | 23.34% | 15.14% | 0.01 | |
| INVAInnoviva, Inc. | 1.48B | 19.76 | 54.89 | 15.54% | 32.78% | 12.61% | 12.75% | 0.65 |
| GLPGGalapagos N.V. | 2.24B | 34.03 | 30.38 | 14.99% | -151.94% | -15.16% | 0.00 | |
| PTGXProtagonist Therapeutics, Inc. | 5.3B | 84.75 | 20.04 | 6.24% | 21.94% | 7.11% | 3.45% | 0.02 |
| ALMSAlumis Inc. Common Stock | 2.84B | 24.17 | -2.33 | -11.08% | -63.71% | 0.12 | ||
| PHATPhathom Pharmaceuticals, Inc. | 1.17B | 14.98 | -2.83 | 80.01% | -186.53% | |||
| ORKAOruka Therapeutics, Inc. | 1.57B | 32.50 | -6.51 | -22.44% | 0.00 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 220.85K | 7.93M | 11.52M | 12.81M | 14.71M | 11.28M | 5.71M | 4.8M | 15.73M | 0 |
| Revenue Growth % | -0.14% | 34.89% | 0.45% | 0.11% | 0.15% | -0.23% | -0.49% | -0.16% | 2.28% | -1% |
| Cost of Goods Sold | 139.94K | 1.42M | 3.43M | 5.03M | 0 | 0 | 9.27M | 20.3M | 0 | 6.81M |
| COGS % of Revenue | 0.63% | 0.18% | 0.3% | 0.39% | - | - | 1.62% | 4.23% | - | - |
| Gross Profit | 80.9K | 7.93M | 11.52M | 12.81M | 14.71M | 11.28M | -3.56M | -15.5M | 15.73M | -6.81M |
| Gross Margin % | 0.37% | 1% | 1% | 1% | 1% | 1% | -0.62% | -3.23% | 1% | - |
| Gross Profit Growth % | -0.11% | 96.98% | 0.45% | 0.11% | 0.15% | -0.23% | -1.32% | -3.35% | 2.01% | -1.43% |
| Operating Expenses | 54.43M | 128M | 185.46M | 203.22M | 192.8M | 170.12M | 93.93M | 101.47M | 92.16M | 113.71M |
| OpEx % of Revenue | 246.44% | 16.15% | 16.1% | 15.86% | 13.11% | 15.09% | 16.46% | 21.14% | 5.86% | - |
| Selling, General & Admin | 18.89M | 48.49M | 61.47M | 82.19M | 70.73M | 44.96M | 23.83M | 17.56M | 31.94M | 23.81M |
| SG&A % of Revenue | 85.52% | 6.12% | 5.34% | 6.41% | 4.81% | 3.99% | 4.17% | 3.66% | 2.03% | - |
| Research & Development | 36.85M | 82.9M | 126.25M | 123.5M | 112.24M | 101.61M | 70.34M | 75.5M | 60.22M | 89.9M |
| R&D % of Revenue | 166.88% | 10.46% | 10.96% | 9.64% | 7.63% | 9.01% | 12.32% | 15.73% | 3.83% | - |
| Other Operating Expenses | -6.44M | -3.65M | -5.21M | -6.96M | 9.83M | 23.55M | -232K | 8.41M | -1K | 0 |
| Operating Income | -54.34M | -122.13M | -173.94M | -190.12M | -171.02M | -158.84M | -98.61M | -96.63M | -76.43M | -120.53M |
| Operating Margin % | -246.03% | -15.41% | -15.1% | -14.84% | -11.63% | -14.09% | -17.28% | -20.13% | -4.86% | - |
| Operating Income Growth % | -0.82% | -1.25% | -0.42% | -0.09% | 0.1% | 0.07% | 0.38% | 0.02% | 0.21% | -0.58% |
| EBITDA | -53.06M | -120.63M | -170.64M | -186.88M | -168.43M | -148.38M | -90.24M | -76.33M | -63.27M | -113.71M |
| EBITDA Margin % | -240.24% | -15.22% | -14.81% | -14.58% | -11.45% | -13.16% | -15.81% | -15.9% | -4.02% | - |
| EBITDA Growth % | -0.83% | -1.27% | -0.41% | -0.1% | 0.1% | 0.12% | 0.39% | 0.15% | 0.17% | -0.8% |
| D&A (Non-Cash Add-back) | 1.28M | 1.49M | 3.3M | 3.24M | 2.6M | 10.46M | 8.38M | 20.3M | 13.16M | 6.81M |
| EBIT | -48.68M | -121.74M | -173.36M | -190.43M | -171.02M | -135.29M | -99.53M | -96.98M | -76.43M | -117.8M |
| Net Interest Income | 953.36K | 1.58M | -3.25M | 162.44K | -1.5M | -724K | -169K | -20.71K | 3.71M | 2.73M |
| Interest Income | 1.11M | 1.59M | 867.09K | 563.94K | 75.05K | 0 | 521K | 406.29K | 3.71M | 2.73M |
| Interest Expense | 159.62K | 17.65K | 3.99M | 479.76K | 1.79M | 724K | 690K | 427K | 0 | 0 |
| Other Income/Expense | 1.04M | 1.66M | -3.25M | 161.53K | -378K | -723K | 424K | 427K | 3.71M | 2.73M |
| Pretax Income | -48.52M | -126.35M | -177.11M | -190.24M | -171.4M | 159.56M | -98.19M | -96.2M | -72.72M | -117.8M |
| Pretax Margin % | -219.7% | -15.94% | -15.38% | -14.85% | -11.65% | 14.15% | -17.2% | -20.04% | -4.62% | - |
| Income Tax | 1.21M | 1.67M | 1.2K | 17.16K | 610K | 10K | -381K | 70K | 7K | -4.08M |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | -1% | 1% | 1% | 1% | 0.97% |
| Net Income | -48.52M | -126.35M | -177.2M | -190.26M | -172.01M | -159.56M | -97.81M | -96.3M | -72.73M | -113.72M |
| Net Margin % | -219.7% | -15.94% | -15.38% | -14.85% | -11.7% | -14.15% | -17.14% | -20.06% | -4.62% | - |
| Net Income Growth % | -0.67% | -1.6% | -0.4% | -0.07% | 0.1% | 0.07% | 0.39% | 0.02% | 0.24% | -0.56% |
| Net Income (Continuing) | -49.54M | -120.55M | -177.2M | -190.26M | -172.01M | -159.56M | -98.05M | -96.27M | -72.73M | -113.72M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -10.35 | -4.90 | -42.00 | -39.25 | -26.40 | -14.75 | -8.90 | -6.20 | -3.80 | -5.90 |
| EPS Growth % | -0.2% | 0.53% | -7.57% | 0.07% | 0.33% | 0.44% | 0.4% | 0.3% | 0.39% | -0.55% |
| EPS (Basic) | -10.35 | -4.90 | -42.00 | -39.25 | -26.40 | -14.75 | -8.90 | -6.20 | -3.80 | -5.90 |
| Diluted Shares Outstanding | 4.7M | 4.89M | 4.95M | 5.79M | 7.4M | 10.82M | 11.02M | 15.48M | 19.02M | 19.23M |
| Basic Shares Outstanding | 4.68M | 4.89M | 4.95M | 5.79M | 7.4M | 10.82M | 11.02M | 15.48M | 19.02M | 19.23M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 399.53M | 300.26M | 220.81M | 198.83M | 204.55M | 207.37M | 114.52M | 223.07M | 158.91M | 44.39M |
| Cash & Short-Term Investments | 385.79M | 282.93M | 194.08M | 167.81M | 193.25M | 196.35M | 77.3M | 209.19M | 141.37M | 32.46M |
| Cash Only | 385.79M | 282.93M | 194.08M | 167.81M | 193.25M | 196.35M | 77.3M | 209.19M | 141.37M | 32.46M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 11.53M | 13.61M | 19.87M | 20.15M | 5.41M | 7.86M | 33.07M | 10.49M | 15.45M | 10.39M |
| Days Sales Outstanding | 19.05K | 626.87 | 629.47 | 574.04 | 134.23 | 254.43 | 2.11K | 798 | 358.43 | - |
| Inventory | 2.21M | 0 | 2.89M | 2.14M | 2.29M | 0 | 0 | 2.68M | 0 | 0 |
| Days Inventory Outstanding | 5.76K | - | 307.4 | 155.23 | - | - | - | 48.19 | - | - |
| Other Current Assets | 12.56M | 0 | 20.79M | 25.25M | 0 | 0 | 0 | 1K | 0 | 0 |
| Total Non-Current Assets | 10.01M | 16.9M | 29.48M | 35.92M | 67.17M | 64.87M | 31.81M | 23.44M | 24.07M | 21.27M |
| Property, Plant & Equipment | 6.66M | 13.77M | 25.07M | 27.64M | 48.6M | 34.9M | 24.92M | 17.61M | 17.93M | 16.81M |
| Fixed Asset Turnover | 0.03x | 0.58x | 0.46x | 0.46x | 0.30x | 0.32x | 0.23x | 0.27x | 0.88x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 661 | 0 | 0 |
| Intangible Assets | 112.14K | 105.9K | 173.14K | 41.01K | 48K | 41K | 22K | 9.34K | 58K | 40K |
| Long-Term Investments | 1.65M | 1.45M | 1.88M | 590.48K | 5.12M | 4.58M | 3.97M | 1.66M | 3.68M | 4.31M |
| Other Non-Current Assets | 731.31K | 674.04K | 1.55M | 5.78M | 13.41M | 25.35M | 2.9M | 5.83M | 2.4M | 111K |
| Total Assets | 409.53M | 317.16M | 250.28M | 234.76M | 271.73M | 272.25M | 146.32M | 246.52M | 182.99M | 65.66M |
| Asset Turnover | 0.00x | 0.02x | 0.05x | 0.05x | 0.05x | 0.04x | 0.04x | 0.02x | 0.09x | - |
| Asset Growth % | 1.07% | -0.23% | -0.21% | -0.06% | 0.16% | 0% | -0.46% | 0.68% | -0.26% | -0.64% |
| Total Current Liabilities | 19.11M | 31.99M | 50.58M | 59.52M | 54M | 52.71M | 31.4M | 29.52M | 37.34M | 31.14M |
| Accounts Payable | 11.97M | 15.14M | 23.85M | 39.05M | 24M | 20.34M | 11.43M | 14.47M | 23.3M | 22.03M |
| Days Payables Outstanding | 31.22K | 3.9K | 2.54K | 2.83K | - | - | 449.9 | 260.24 | - | 1.18K |
| Short-Term Debt | 410.39K | 813.04K | 3.89M | 3.49M | 4.33M | 4.43M | 3.51M | 1.13M | 883K | 846K |
| Deferred Revenue (Current) | 943.66K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Other Current Liabilities | 5.33M | 10.33M | 18.31M | 2.92M | 21.63M | 22.68M | 12.13M | 9.82M | 11.79M | 7.42M |
| Current Ratio | 20.90x | 9.38x | 4.37x | 3.34x | 3.79x | 3.93x | 3.65x | 7.56x | 4.26x | 1.43x |
| Quick Ratio | 20.79x | 9.38x | 4.31x | 3.30x | 3.75x | 3.93x | 3.65x | 7.47x | 4.26x | 1.43x |
| Cash Conversion Cycle | -6.42K | - | -1.6K | -2.1K | - | - | - | 585.95 | - | - |
| Total Non-Current Liabilities | 6.18M | 17.26M | 16.83M | 9.46M | 24.54M | 14.04M | 15.9M | 22.54M | 5.46M | 7.13M |
| Long-Term Debt | 5.6M | 4.47M | 2.57M | 1.75M | 810K | 543K | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 22M | 10.5M | 7.15M | 1.13M | 4.53M | 6.3M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 584.57K | 12.8M | 14.26M | 7.71M | 1.74M | 3M | 8.75M | 21.42M | 934K | 838K |
| Total Liabilities | 25.3M | 49.26M | 67.4M | 68.98M | 78.54M | 66.75M | 47.29M | 52.06M | 42.8M | 38.27M |
| Total Debt | 6.01M | 5.28M | 6.46M | 5.24M | 27.14M | 15.47M | 10.66M | 4.15M | 6.55M | 7.8M |
| Net Debt | -379.78M | -277.65M | -187.62M | -162.57M | -166.12M | -180.88M | -66.64M | -205.04M | -134.81M | -24.66M |
| Debt / Equity | 0.02x | 0.02x | 0.04x | 0.03x | 0.14x | 0.08x | 0.11x | 0.02x | 0.05x | 0.28x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -340.40x | -6919.26x | -43.60x | -396.28x | -95.49x | -219.40x | -142.92x | -226.30x | - | - |
| Total Equity | 384.24M | 267.9M | 182.88M | 165.78M | 193.19M | 205.49M | 99.03M | 194.45M | 140.19M | 27.39M |
| Equity Growth % | 1.11% | -0.3% | -0.32% | -0.09% | 0.17% | 0.06% | -0.52% | 0.96% | -0.28% | -0.8% |
| Book Value per Share | 81.82 | 54.77 | 36.94 | 28.66 | 26.10 | 18.99 | 8.99 | 12.56 | 7.37 | 1.42 |
| Total Shareholders' Equity | 384.24M | 267.9M | 182.88M | 165.78M | 193.19M | 205.49M | 99.03M | 194.45M | 140.19M | 27.39M |
| Common Stock | 2.89M | 2.72M | 3.52M | 4.12M | 5.64M | 6.52M | 6.54M | 10.72M | 10.97M | 11.65M |
| Retained Earnings | -53.3M | -126.35M | -207.9M | -227M | -798.99M | -958.54M | -98.05M | -259.58M | -238.86M | -286.38M |
| Treasury Stock | 0 | -1.31M | 0 | 0 | -230K | -1.17M | 0 | -1.11M | -1.26M | -1.31M |
| Accumulated OCI | -47.22M | -56.23M | -185.23M | -348.47M | -643.87M | 6.64M | -15.39M | -13.8M | -8.13M | -12.19M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -31.93M | -65.68M | -160.91M | -186.74M | -148.35M | -165.61M | -108.24M | -55.7M | -79.65M | -104.47M |
| Operating CF Margin % | -144.57% | -8.29% | -13.97% | -14.57% | -10.09% | -14.69% | -18.96% | -11.6% | -5.06% | - |
| Operating CF Growth % | 0.02% | -1.06% | -1.45% | -0.16% | 0.21% | -0.12% | 0.35% | 0.49% | -0.43% | -0.31% |
| Net Income | -53.3M | -126.35M | -207.9M | -227M | -172.01M | -159.56M | -97.81M | -96.27M | -72.73M | -113.92M |
| Depreciation & Amortization | 1.28M | 1.49M | 4.12M | 3.87M | 2.6M | 10.46M | 8.38M | 13.16M | -14M | -925K |
| Stock-Based Compensation | 12.43M | 37.9M | 43.33M | 35.41M | 17.24M | -1.13M | 3.12M | 5.03M | 6.02M | 4.62M |
| Deferred Taxes | 149.12K | 126.86K | 323.75K | 403.22K | 0 | 0 | 184K | 0 | 0 | 0 |
| Other Non-Cash Items | 353.13K | 163.27K | 182.99K | 1.03M | 381K | 220K | 656K | 66K | 99K | -3K |
| Working Capital Changes | 7.16M | 20.99M | -968.44K | -445.6K | 3.45M | -15.6M | -22.77M | 22.32M | 953K | 5.75M |
| Change in Receivables | 162.25K | -1.38M | 4.22K | 1.68M | 34K | -2.07M | 2.15M | 0 | 0 | 0 |
| Change in Inventory | 147.93K | -2.17M | -5M | -2.14M | -527K | 2.33M | -16.18M | 0 | 0 | 0 |
| Change in Payables | 9.83M | 4.02M | 4.69M | 12.43M | -7.65M | -5.08M | -7.56M | 3.46M | 8.42M | 272K |
| Cash from Investing | -6.38M | -9.16M | -11.03M | -11.81M | -5.66M | -2.87M | -433K | -100K | -808K | -757K |
| Capital Expenditures | -5.38M | -9.05M | -10.62M | -6.49M | -5.57M | -2.79M | -918K | -754K | -677K | -2.34M |
| CapEx % of Revenue | 24.35% | 1.14% | 0.92% | 0.51% | 0.38% | 0.25% | 0.16% | 0.16% | 0.04% | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -30K | 26K | 604K | -611 | 0 | 1.58M |
| Cash from Financing | 287.53M | 1.84M | 402.58K | 178.62M | 207.58M | 149.55M | 274K | 194.1M | 6.77M | 587K |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | -1.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -26.25K | 83.23K | -163.03K | -506.34K | 3.29M | -35K | -121.08K | -20K | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -37.31M | -74.73M | -171.53M | -193.23M | -153.94M | -168.42M | -109.16M | -56.45M | -80.33M | -106.81M |
| FCF Margin % | -168.92% | -9.43% | -14.89% | -15.08% | -10.47% | -14.94% | -19.12% | -11.76% | -5.11% | - |
| FCF Growth % | -0.1% | -1% | -1.3% | -0.13% | 0.2% | -0.09% | 0.35% | 0.48% | -0.42% | -0.33% |
| FCF per Share | -7.94 | -15.28 | -34.64 | -33.40 | -20.80 | -15.57 | -9.91 | -3.65 | -4.22 | -5.55 |
| FCF Conversion (FCF/Net Income) | 0.66x | 0.52x | 0.91x | 0.98x | 0.86x | 1.04x | 1.11x | 0.58x | 1.10x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -17.13% | -38.75% | -78.62% | -109.14% | -95.84% | -80.04% | -64.24% | -65.63% | -43.47% | -135.72% |
| Return on Invested Capital (ROIC) | -651.79% | - | - | -4441.01% | -847.19% | -461.04% | -259.52% | -664.89% | -1067.09% | -2231.7% |
| Gross Margin | 36.63% | 100% | 100% | 100% | 100% | 100% | -62.46% | -322.9% | 100% | - |
| Net Margin | -21969.51% | -1593.88% | -1538.29% | -1484.65% | -1169.51% | -1415% | -1713.54% | -2006.25% | -462.4% | - |
| Debt / Equity | 0.02x | 0.02x | 0.04x | 0.03x | 0.14x | 0.08x | 0.11x | 0.02x | 0.05x | 0.28x |
| Interest Coverage | -340.40x | -6919.26x | -43.60x | -396.28x | -95.49x | -219.40x | -142.92x | -226.30x | - | - |
| FCF Conversion | 0.66x | 0.52x | 0.91x | 0.98x | 0.86x | 1.04x | 1.11x | 0.58x | 1.10x | 0.92x |
| Revenue Growth | -13.93% | 3489.36% | 45.31% | 11.25% | 14.77% | -23.33% | -49.38% | -15.91% | 227.67% | -100% |
DBV Technologies S.A. (DBVT) reported $0.5M in revenue for fiscal year 2024. This represents a 213% increase from $0.2M in 2011.
DBV Technologies S.A. (DBVT) saw revenue decline by 100.0% over the past year.
DBV Technologies S.A. (DBVT) reported a net loss of $125.5M for fiscal year 2024.
DBV Technologies S.A. (DBVT) has a return on equity (ROE) of -135.7%. Negative ROE indicates the company is unprofitable.
DBV Technologies S.A. (DBVT) had negative free cash flow of $98.3M in fiscal year 2024, likely due to heavy capital investments.